Cefalù Angelo B, Barraco Giacoma, Noto Davide, Valenti Vincenza, Barbagallo Carlo M, Elisir Gerardo D, Cuniberti Luis A, Werba José P, Libra Massimo, Costa Salvatore, Gianguzza Fabrizio, Notarbartolo Alberto, Travali Salvatore, Averna Maurizio R
Department of Internal Medicine and Geriatrics, University of Palermo, Italy.
Int J Mol Med. 2006 Mar;17(3):539-46.
Familial hypercholesterolemia (FH) is an autosomal dominant inherited disease caused by mutations in the gene coding for the low density lipoprotein receptor (LDL-R). It is characterized by a high concentration of low density lipoprotein (LDL), which frequently gives rise to premature coronary artery disease. We studied the probands of five FH Sicilian families with 'definite' FH and one proband of Paraguayan descent with homozygous FH who has been treated with an effective living-donor liver transplantation. In order to seek the molecular defect in these six families, we used direct sequencing to define the molecular defects of the LDL-R gene responsible for the disease. We described three novel missense mutations (C100Y, C183Y and G440C), two frameshift mutations (g.1162delC in exon 8 and g.2051delC in exon 14) and one mutation (g.2390-1Gright curved arrow A) at splicing acceptor consensus sequences located in intron 16 of the LDL-R gene; the analysis of cDNA of this splicing mutation showed the activation of a cryptic splice site in intron 16 and the binding studies showed a reduction in internalisation of LDL-DIL in the proband's cultured fibroblasts. Moreover, a g.2051delC in exon 14 was identified in the proband of Paraguayan ancestry with clinical features of homozygous FH. The mutation identified in the South American patient represents the first description of a variant in South American patients other than Brazilian FH patients. The 5 mutations identified in the Sicilian patients confirm the heterogeneity of LDL-R gene mutations in Sicily.
家族性高胆固醇血症(FH)是一种常染色体显性遗传性疾病,由编码低密度脂蛋白受体(LDL-R)的基因突变引起。其特征是低密度脂蛋白(LDL)浓度升高,这常导致早发性冠状动脉疾病。我们研究了五个患有“确诊”FH的西西里家族的先证者以及一名患有纯合子FH的巴拉圭裔先证者,该先证者已接受有效的活体供肝移植治疗。为了探寻这六个家族中的分子缺陷,我们采用直接测序法来确定导致该疾病的LDL-R基因的分子缺陷。我们描述了三个新的错义突变(C100Y、C183Y和G440C)、两个移码突变(外显子8中的g.1162delC和外显子14中的g.2051delC)以及位于LDL-R基因第16内含子剪接受体共有序列处的一个突变(g.2390-1G→A);对该剪接突变的cDNA分析显示第16内含子中一个隐蔽剪接位点的激活,结合研究表明先证者培养的成纤维细胞中LDL-DIL内化减少。此外,在具有纯合子FH临床特征的巴拉圭裔先证者中鉴定出了外显子14中的g.2051delC。在南美患者中鉴定出的该突变是除巴西FH患者外南美患者中一种变异的首次描述。在西西里患者中鉴定出的5个突变证实了西西里LDL-R基因突变的异质性。